Nokin, M., Darbo, E., Travert, C., Drogat, B., Lacouture, A., San José, S., . . . Ambrogio, C. (2020). Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
Citación estilo ChicagoNokin, Marie-Julie, et al. Inhibition of DDR1 Enhances in Vivo Chemosensitivity in KRAS-mutant Lung Adenocarcinoma. 2020.
Cita MLANokin, Marie-Julie, et al. Inhibition of DDR1 Enhances in Vivo Chemosensitivity in KRAS-mutant Lung Adenocarcinoma. 2020.
Precaución: Estas citas no son 100% exactas.